Impact of EGFR Gene Polymorphisms on Anticancer Drug Cytotoxicity In Vitro

Author： Puyo Stéphane   Valérie Le Morvan   Robert Jacques  

Publisher： Adis International

ISSN： 1177-1062

Source： Molecular Diagnosis & Therapy, Vol.12, Iss.4, 2008-01, pp. : 225-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation

By Wei Wei   Yue Zhan-Guo   Qu Jian-Bo   Yue Hua   Su Zhi-Guo   Ma Guang-Hui  

Nanomedicine, Vol. 5, Iss. 4, 2010-06 ,pp. : 589-596

Future Medicine

Access to resources Recommend Favorite

EGFR Signaling and Drug Discovery

By  

Oncology, Vol. 77, Iss. 6, 2010-02 ,pp. : 400-410

Karger

Access to resources Recommend Favorite

Amphiphilic curcumin conjugate-forming nanoparticles as anticancer prodrug and drug carriers: in vitro and in vivo effects

By Tang Huadong   Murphy Caitlin J   Zhang Bo   Shen Youqing   Sui Meihua   Van Kirk Edward Alva   Feng Xiaowen   Murdoch William J  

Nanomedicine, Vol. 5, Iss. 6, 2010-08 ,pp. : 855-865

Future Medicine

Access to resources Recommend Favorite

P27 and P53 Gene Polymorphisms and Restenosis following Coronary Implantation of Drug-Eluting Stents

By  

Cardiology, Vol. 112, Iss. 4, 2008-08 ,pp. : 263-269

Karger

Access to resources Recommend Favorite

Impact of single nucleotide polymorphisms of cytarabine metabolic genes on drug toxicity in childhood acute lymphoblastic leukemia

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 622-628

John Wiley & Sons Inc

Access to resources Recommend Favorite